Erratum to: Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter (Breast Cancer Res Treat, (2012) 134, (569-581), 10.1007/s10549-012-2090-9);Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter

Breast Cancer Research and Treatment

Volumn 134, Issue 2, 2012, Pages 569-581

  Bartella, V ^a   Rizza, P ^a   Barone, I ^a   Zito, D ^a   Giordano, F ^a   Giordano, C ^a   Catalano, S ^a   Mauro, L ^a   Sisci, D ^a   Panno, M L ^a   Fuqua, S A W ^a,b   Ando S ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor alpha; Estrogen receptor beta; NCoR corepressor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NUCLEAR RECEPTOR COREPRESSOR; TRANSCRIPTION FACTOR SP1;

ACETYLATION; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BASE COMPOSITION; DOWN REGULATION; ESTROGEN RECEPTOR ALPHA GENE; GENE DELETION; GENE FUNCTION; GENE OVEREXPRESSION; MUTATIONAL ANALYSIS; NCOR GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RECEPTOR GENE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; TRANSIENT TRANSFECTION; TUMOR GENE;

EID: 84868092904     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-016-3753-8     Document Type: Erratum

References (69)

1. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
2. Heldring N, Pike A, Andersson S et al (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905-931
3. Osborne CK, Schiff R, Fuqua SA et al (2001) Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res 7:4338s-4342s (discussion 4411s-4412s)
4. Barone I, Brusco L, Fuqua SA (2010) Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin Cancer Res 16:2702-2708 Review
5. Cato AC, Nestl A, Mink S (2002) Rapid actions of steroid receptors in cellular signaling pathways. Science STKE 138:re9
6. Nemere I, Pietras RJ, Blackmore PF (2003) Membrane receptors for steroid hormones: signal transduction and physiological significance. J Cell Biochem 88:438-445
7. Ordonez-Moran P, Munoz A (2009) Nuclear receptors: genomic and nongenomic effects converge. Cell Cycle 8:1675-1680
8. Paech K, Webb P, Kuiper GG et al (1997) Differential ligand activation of estrogen receptors ERa and ERb at AP1 sites. Science 277:1508-1510
9. Webb P, Nguyen P, Valentine C et al (1999) The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol 13:1672-1685
10. Kushner PJ, Agard DA, Greene GL et al (2000) Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317
11. Salvatori L, Pallante P, Ravenna L et al (2003) Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER a and b subtypes via an Sp1 site. Oncogene 22:4875-4881
12. Safe S, Kim K (2004) Nuclear receptor-mediated transactivation through interaction with Sp proteins. Nucleic Acid Res Mol Biol 77:1-36
13. Panno ML, Mauro L, Marsico S et al (2006) Evidence that mouse IRS-1 belongs to the family gene which promoter is activated by ERa through its interaction with Sp-1. J Mol Endocrinol 36:91-105
14. Catalano S, Rizza P, Gu G et al (2007) Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol in situ production. J Cell Physiol 211:448-456
15. Mauro L, Catalano S, Bossi G et al (2007) Evidences that leptin upregulates E-cadherin expression in breast cancer effects on tumor growth and progression. Cancer Res 67:3412-3421
16. Higgins KJ, Shengxi L, Abdelrahim M et al (2008) Vascular endothelial growth factor receptor-2 expression is down-regulated by 17 beta estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp-1 proteins. Mol Endocrinol 22:388-402
17. Varlakhanova N, Snyder C, Jose S et al (2010) Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain. Mol Cell Biol 30:1434-1445
18. Allegra JC, Lippman ME, Green L et al (1979) Estrogen receptor values in patients with benign breast disease. Cancer 44:228-231
19. Petersen OW, Hoyer PE, Van Deurs B (1987) Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47:5748-5751
20. Ricketts D, Turnbull L, Ryall G et al (1991) Estrogen and progesterone receptors in the normal female breast. Cancer Res 51:1817-1822
21. Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270-282
22. Zhao C, Dahlman-Wright K et al (2008) Estrogen receptor beta: an overview and update. Nucl Recept Signal 6:e003
23. Skliris GP, Munot K, Bell SM et al (2003) Reduced expression of estrogen receptor beta in invasive breast cancer and its reexpression using DNA methyl transferase inhibitors in a cell line model. J Pathol 201:213-220
24. Hopp TA, Weiss HL, Parra IS et al (2004) Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10:7490-7499
25. Paruthiyil S, Parmar H, Kerekatte V et al (2004) Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing a G2 Cell Cycle Arrest. Cancer Res 64:423-428
26. Chang EC, Frasor J, Komm B et al (2006) Impact of estrogen receptor b on gene networks regulated by estrogen receptor a in breast cancer cells. Endocrinology 147:4831-4842
27. Williams C, Edvardsson K, Lewandowski SA et al (2008) A genome-wide study of repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 27:1019-1032
28. Ström A, Hartman J, Foster JS et al (2004) Estrogen receptor b inhibits 17b-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci 101:1566-1571
29. Hartman J, Lindberg K, Morani A et al (2006) Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66:11207-11213
30. Saji S, Omoto Y, Shimizu C et al (2002) Expression of estrogen receptor (ER) (beta) cx protein in ER (alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62:4849-4853
31. Buteau-Lozano H, Ancelin M, Lardeux B et al (2002) Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors a and b. Cancer Res 62:4977-4984
32. Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y et al (2003) Estrogen receptor (ER) b1 and ERbcx/b ERa function differently in breast cancer cell line MCF7. Oncogene 22:5011-5020
33. Pettersson K, Delaunay F, Gustafsson JA (2000) Estrogen receptor b acts as a dominant regulator of estrogen signaling. Oncogene 19:4970-4978
34. Nilsson S, Makela S, Treuter E et al (2001) Mechanisms of estrogen action. Physiol Rev 81:1535-1565
35. Liu MM, Albanese C, Anderson CM et al (2002) Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 277:24353-24360
36. Acconcia F, Totta P, Ogawa S et al (2005) Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 203:193-201
37. De Graffenried LA, Hopp TA, Valente AJ et al (2004) Regulation of the estrogen receptor a minimal promoter by Sp1, USF-1 and ERa. Breast Cancer Res and Treat 85:111-120
38. Catalano S, Malivindi R, Giordano C et al (2010) Farnesoid X Receptor through its binding to Steroidogenic Factor 1 responsive element inhibits aromatase expression in tumor Leydig cells. J Biol Chem 285:5581-5593
39. Andrews NC, Faller DV (1991) A rapid microperation technique foe extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499
40. Barone I, Cui Y, Herynk MH et al (2009) Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3 K/Akt kinase pathway. Cancer Res 69:4724-4732
41. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
42. Zamir I, Dawson J, Lavinsky RM et al (1997) Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci USA 94:14400-14405
43. Huynh KD, Fischle W, Verdin E et al (2000) BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 14:1810-1823
44. Lee JA, Suh DC, Kang JE et al (2005) Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J Biol Chem 280:28061-28071
45. Panno ML, Salerno M, Pezzi V et al (1996) Effect of estradiol and insulin on proliferative pattern and on estrogen and progesterone receptor contents in MCF-7 cells. J Cancer Res Clin Oncol 122:745-749
46. Lee AV, Weng C-N, Jackson JG et al (1997) Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol 152:39-47
47. Andò S, Panno ML, Salerno M et al (1998) Role of IRS-1 signaling in insulin-induced modulation of estrogen receptors in breast cancer cells. Biochem Biophys Res Commun 253:315-319
48. Lannigan DA (2003) Estrogen receptor phosphorylation. Steroids 68:1-9
49. Leygue E, Dotzlaw H, Watson PH et al (1998) Altered estrogen receptor a and b messenger RNA expression during human breast tumorigenesis. Cancer Res 58:3197-3201
50. Jarvinen TA, Pelto-Huikko M, Holli K et al (2000) Estrogen receptor b is coexpressed with ERa and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156:29-35
51. Roger P, Sahla ME, Makela S et al (2001) Decreased expression of estrogen receptor b protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541
52. Fixemer T, Remberger K, Bonkhoff H (2003) Differential expression of the estrogen receptor beta in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54:79-87
53. Foley EF, Jazaeri AA, Shupnik MA et al (2000) Selective loss of estrogen receptor b in malignant human colon. Cancer Res 60:245-248
54. Pujol P, Rey JM, Nirde P et al (1998) Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 58:5367-5373
55. Behrens D, Gill JH, Fichtner I (2007) Loss of tumourigenicity of stably ERb-transfected MCF-7 breast cancer cells. Mol Cell Endocrinol 274:19-29
56. Song K, Pan ZZ (2012) Estrogen receptor beta agonist diarylpropionitrile counteracts the estrogenic activity of estrogen receptor alpha agonist propylpyrazole-triol in the mammary gland of ovariectomized Sprague Dawley rats. J Steroid Biochem Mol Biol 130:26-35
57. Mann S, Laucirica R, Carlson N et al (2001) Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32:113-118
58. Murphy LC, Leygue E, Niu Y et al (2002) Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. Br J Cancer 87:1411-1416
59. Esslimani-Sahla M, Simony-Lafontaine J, Kramar A et al (2004) Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res 10:5769-5776
60. Saville B, Wormke M, Wang F et al (2000) Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
61. Porter W, Saville B, Hoivik D et al (1997) Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
62. Duan R, Porter W, Safe S (1998) Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
63. Vyhlidal C, Samudio I, Kladde MP et al (2000) Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response half-site. J Mol Endocrinol 24:329-338
64. Nagy L, Kao HY, Chakravarti D et al (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
65. Hu X, Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96
66. Webb P, Anderson CM, Valentine C et al (2000) The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14:1976-1985
67. Jiang S, Meyer R, Kang K et al (2006) Scaffold attachment factor SAFB1 suppresses estrogen receptor a-mediated transcription in part via interaction with nuclear receptor corepressor. Mol Endocrinol 20:311-320
68. De Amicis F, Zupo S, Panno ML et al (2009) Progesterone receptor B recruits a repressor complex to a half-TRE site of the estrogen receptor a gene promoter. Mol Endocrinol 23:454-465
69. Ghisletti S, Huang W, Jepsen K et al (2009) Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Gene Dev 23:681-693